TearCare System to Treat Dry Eye Disease

Exclusion criteria

• ✕. Restasis or Xiidra within 60 days prior to enrollment;
• ✕. Antihistamines (oral or topical) within 10 days prior to enrollment;
• ✕. Systemic medication(s) (other than anti-histamines) that is known to cause ocular dryness (e.g. diuretics, anti-hypertensives, anti-depressants, hormone therapy) and whose dose of this medication(s) has not been stable within 30 days prior to enrollment. There must be no anticipated adjustments to the dose of these medications for the duration of the trial;
• ✕. Accutane (at any time);
• ✕. Oral tetracyclines or azithromycin within 30 days prior to enrollment; or
• ✕. Topical ophthalmic antibiotics, anti-glaucoma medications, steroids, non-steroidal anti-inflammatory medications within 30 days prior to enrollment.
• ✕. Office-based dry eye treatment (e.g. IPL, thermal pulsation \[Lipiflow\], etc.) within 12 months prior to enrollment;
• ✕. Meibomian gland expression within 6 months prior to enrollment;